About Optimer Pharmaceuticals
Optimer Pharmaceuticals is a company based in San Diego (United States) founded in 1998 was acquired by Cubist Pharmaceuticals in July 2013. Optimer Pharmaceuticals has raised $34.2 million across 5 funding rounds from investors including Fubon Financial Holdings, Cubist Pharmaceuticals and HHS. Optimer Pharmaceuticals operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
- Headquarter San Diego, United States
- SectorsHealthcare
- Website optimerpharma.com
- Social LinkedIn X
- Acquired by Cubist Pharmaceuticals (Jul 2013)
- Total Equity Funding$34.2M (USD)
in 5 rounds
- Latest Funding Round$2M (USD), Grant
Aug 2009
- InvestorsFubon Financial Holdings
& 11 more
- Acquired byCubist Pharmaceuticals
(Jul 2013)
Funding Insights of Optimer Pharmaceuticals
Optimer Pharmaceuticals has successfully raised a total of $34.2M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $2 million completed in August 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $34.2M
- Total Rounds 5
- Last Round Grant — $2M
- First Round $12M
(Apr 2005)
- Investors Count 11
All 5 funding rounds of Optimer Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2009 | $2M | Grant | – | – | |
| Sep 2007 | $2M | Grant | – | – | |
| Nov 2005 | $22.2M | Series D | – | – | |
| Jul 2005 | $2M | Grant | – | – | |
| Apr 2005 | $12M | Series C | – | – |
12 investors in total: 12 institutional.
Investors in Optimer Pharmaceuticals
Optimer Pharmaceuticals has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Fubon Financial Holdings, Cubist Pharmaceuticals and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | proquestvc.com | - | |
- | – | bbbiotechventures.com | - | |
- | – | sblifescience.jp | - | |
Limited information is provided about UOB Venture Management. | – | uobvm.com.sg | Singapore, Singapore | |
Sector-agnostic investments are made in early-stage Asia Pacific startups. | 1959 | cdibcapitalgroup.com | Taipei, Taiwan | |
Life and property insurance services are provided via internet-first platforms. | 2001 | fubon.com | Taipei, Taiwan | |
- | – | gscorporation.com | - | |
Petrochemical-based products are supplied across Asia-Pacific by the company. | 1975 | oucc.com.tw | Taipei, Taiwan | |
Pulp, paper, printing, and electronic components are manufactured. | 1924 | yfy.com | Taipei, Taiwan | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Optimer Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Optimer Pharmaceuticals
4 dated milestones of Optimer Pharmaceuticals across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Optimer Pharmaceuticals is founded.
- Funding First funding round of $12.0M.
- Funding Latest funding round, Grant, of $2.0M.
- Exit Acquired by Cubist Pharmaceuticals.
Competitors of Optimer Pharmaceuticals
Optimer Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| eurofins.com | 1987 | Luxembourg | – | – | Laboratory testing and contract research services are provided globally. | |
| wuxiapptec.com | 2000 | Shanghai, China | $40M | 1,681 | Provider of CRO and CDMO services | |
| ipsen.com | 1929 | – | – | 505 | Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | |
| cheplapharm.com | 1998 | Mesekenhagen, Germany | – | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | |
| anipharmaceuticals.com | 1996 | Baudette, United States | – | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | |
| caidya.com | 2003 | Morrisville, United States | $373M | 351 | CRO focused on clinical development for phases II & III clinical trials and regulatory affair services | |
| rednucleus.com | 2014 | Yardley, United States | – | 176 | Advisory, scientific, and medical communications provided for pharmaceutical industry. | |
| aptar.com | 1992 | Crystal Lake, United States | – | 232 | Regulatory support, brand differentiation, and prototyping services are provided. | |
| aliadatx.com | 2021 | Boston, United States | $33M | – | Provider of drug research & development services for multiple therapeutic areas |
Detailed competitors of Optimer Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Optimer Pharmaceuticals
Websites that share an audience with Optimer Pharmaceuticals (optimerpharma.com).
Websites whose visitors overlap most with Optimer Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| genomichealth.com | 100% | 1.9K | #5,157,031 | View details | |
| theravance.com | 100% | 4.4K | #4,418,406 | View details | |
| cepheid.com | 100% | 117.9K | #496,659 | View details | |
invernessmedical.com | invernessmedical.com | 100% | – | – | – |
| viropharma.com | 100% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Optimer Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Optimer Pharmaceuticals
10 companies that operate in the same segment as Optimer Pharmaceuticals (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Optimer Pharmaceuticals
Optimer Pharmaceuticals was founded in 1998 and raised its 1st funding round 7 years after it was founded.
Optimer Pharmaceuticals is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Optimer Pharmaceuticals is a funded company, having raised a total of $34.2M across 5 funding rounds to date. The company's 1st funding round was a Series C of $12M, raised on Apr 2005.
Optimer Pharmaceuticals was founded in 1998 and is headquartered in San Diego, United States. Operations are focused within the pharmaceutical sector, where drug discovery and development activities are carried out. The companys domain, optimerpharma.com, is maintained as its online platform. Specific details on services and products remain limited in available records. Geography is centered in the United States, supporting industry-related endeavors.
Optimer Pharmaceuticals's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Optimer Pharmaceuticals has 12 investors. Key investors include Fubon Financial Holdings, Cubist Pharmaceuticals, HHS, CDIB Capital Group, and Par Pharmaceutical Companies.
Yes. Optimer Pharmaceuticals was acquired by Cubist Pharmaceuticals in July 2013.